1. Home
  2. STGW vs TXG Comparison

STGW vs TXG Comparison

Compare STGW & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stagwell Inc.

STGW

Stagwell Inc.

HOLD

Current Price

$5.84

Market Cap

1.4B

Sector

N/A

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$17.96

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
STGW
TXG
Founded
1980
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
STGW
TXG
Price
$5.84
$17.96
Analyst Decision
Buy
Buy
Analyst Count
6
13
Target Price
$8.46
$14.73
AVG Volume (30 Days)
1.4M
2.6M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
1954.71
N/A
EPS
0.06
N/A
Revenue
$2,890,264,000.00
$641,814,000.00
Revenue This Year
$4.53
$4.50
Revenue Next Year
$7.81
N/A
P/E Ratio
$102.15
N/A
Revenue Growth
6.75
1.92
52 Week Low
$4.03
$6.78
52 Week High
$7.66
$20.34

Technical Indicators

Market Signals
Indicator
STGW
TXG
Relative Strength Index (RSI) 64.09 56.42
Support Level $5.51 $17.32
Resistance Level $5.79 $19.29
Average True Range (ATR) 0.20 1.07
MACD 0.05 -0.21
Stochastic Oscillator 95.30 37.35

Price Performance

Historical Comparison
STGW
TXG

About STGW Stagwell Inc.

Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; and Communications Network. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: